<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Morton Grove Pharmaceuticals Inc. et al.; Withdrawal of Approval of Seven Abbreviated New Drug Applications; Correction</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Morton Grove Pharmaceuticals Inc. et al.; Withdrawal of Approval of Seven Abbreviated New Drug Applications; Correction</h1>
    <p class="timestamp">Published: 2021-05-20 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of March 5, 2021. The document announced the withdrawal of approval of seven abbreviated new drug applications (ANDAs) from multiple applicants as of April 5, 2021. The document indicated that FDA was withdrawing approval of the following five ANDAs, after receiving a withdrawal request from Neopharma, Inc., 211 College Road East, Suite 101, Princeton, NJ 08540: ANDA 078383, Pioglitazone Hydrochlo...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2021-10588</p>
    <p><strong>Publication Date:</strong> 2021-05-20</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2021/05/20/2021-10588/morton-grove-pharmaceuticals-inc-et-al-withdrawal-of-approval-of-seven-abbreviated-new-drug">https://www.federalregister.gov/documents/2021/05/20/2021-10588/morton-grove-pharmaceuticals-inc-et-al-withdrawal-of-approval-of-seven-abbreviated-new-drug</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2021-10588</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
